Research output per year
Research output per year
Search results
-
2022
Conolidine analogues as selective ACKR3 modulators for the treatment of cancer and cardiovascular diseases
Chevigne, A., Szpakowska, M., Namjoshi, O. A., Blough, B. E., Decker, A. M. & Meyrath, M., 30 Jun 2022, IPC No. A61K31/397; A61K31/4025; A61K31/404; A61K31/407; A61K31/439; A61K31/4439; A61K31/454; A61K31/496; A61K31/499; A61K31/551; A61P13/12; A61P17/02; A61P25/28; A61P29/00; A61P3/04; A61P31/12; A61P31/18; A61P35/00; A61P37/08; A61P9/00; A61P9/10; C07D401/06; C07D403/06; C07D403/12; C07D471/18; C07D487/04;, Patent No. WO2022136486A1, 22 Dec 2021, Priority date 22 Dec 2020, Priority No. EP20216606AResearch output: Patent
-
2021
Specific ACKR2 modulators for use in therapy
Janji, B., Noman, M. Z., Chevigne, A., Szpakowska, M., Berchem, G. & Ollert, M., 21 Jan 2021, IPC No. A61K39/395; A61K48/00; A61P35/00; C07K16/28; C12N15/113, Patent No. WO 2021/009251, 15 Jul 2020, Priority date 15 Jul 2019, Priority No. EP19186373AResearch output: Patent
Open Access -
2020
Fusion proteins comprising a cytokine and scaffold protein
Steyaert, J., Pardon, E., Wohlkönig, A., Kalichuk, V., Vranken, W., Uchanski, T., Chevigné, A. & Szpakowska, M., 25 Jun 2020, IPC No. C07K14/205; C07K14/52; C07K14/715; C07K19/00, Patent No. WO2020127983A1, Priority date 21 Dec 2018, Priority No. EP18215463AResearch output: Patent
-
Novel selective ACKR3 modulators and uses thereof
Chevigne, A., Meyrath, M. & Szpakowska, M., 12 Nov 2020, IPC No. A61K38/00; A61K47/62; A61K47/64; A61K48/00; C07K7/08; C12N15/86; G01N33/58, Patent No. WO 2020/225070A1, 30 Apr 2020, Priority date 3 May 2019, Priority No. EP19172560AResearch output: Patent
Open Access